Centene Debt to Equity Ratio 2012-2026 | CNC
Current and historical debt to equity ratio values for Centene (CNC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Centene debt/equity for the three months ending March 31, 2026 was 0.87.
| Centene Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-03-31 | $59.67B | $21.50B | 2.78 |
| 2025-12-31 | $56.71B | $20.03B | 2.83 |
| 2025-09-30 | $61.06B | $21.03B | 2.90 |
| 2025-06-30 | $58.90B | $27.49B | 2.14 |
| 2025-03-31 | $59.04B | $28.01B | 2.11 |
| 2024-12-31 | $55.95B | $26.50B | 2.11 |
| 2024-09-30 | $54.96B | $27.40B | 2.01 |
| 2024-06-30 | $55.70B | $27.44B | 2.03 |
| 2024-03-31 | $55.58B | $27.05B | 2.06 |
| 2023-12-31 | $58.70B | $25.94B | 2.26 |
| 2023-09-30 | $58.99B | $25.40B | 2.32 |
| 2023-06-30 | $57.09B | $25.77B | 2.22 |
| 2023-03-31 | $57.82B | $25.17B | 2.30 |
| 2022-12-31 | $52.69B | $24.18B | 2.18 |
| 2022-09-30 | $55.64B | $25.53B | 2.18 |
| 2022-06-30 | $54.63B | $26.43B | 2.07 |
| 2022-03-31 | $55.59B | $27.31B | 2.04 |
| 2021-12-31 | $51.44B | $26.94B | 1.91 |
| 2021-09-30 | $51.15B | $26.59B | 1.92 |
| 2021-06-30 | $45.49B | $26.05B | 1.75 |
| 2021-03-31 | $43.83B | $26.46B | 1.66 |
| 2020-12-31 | $42.83B | $25.89B | 1.66 |
| 2020-09-30 | $42.52B | $25.84B | 1.65 |
| 2020-06-30 | $43.18B | $25.17B | 1.72 |
| 2020-03-31 | $42.78B | $23.66B | 1.81 |
| 2019-12-31 | $28.34B | $12.66B | 2.24 |
| 2019-09-30 | $21.85B | $12.41B | 1.76 |
| 2019-06-30 | $22.12B | $12.25B | 1.81 |
| 2019-03-31 | $21.94B | $11.63B | 1.89 |
| 2018-12-31 | $19.89B | $11.01B | 1.81 |
| 2018-09-30 | $20.41B | $10.75B | 1.90 |
| 2018-06-30 | $18.05B | $10.70B | 1.69 |
| 2018-03-31 | $17.59B | $7.58B | 2.32 |
| 2017-12-31 | $14.99B | $6.86B | 2.18 |
| 2017-09-30 | $15.35B | $6.65B | 2.31 |
| 2017-06-30 | $15.45B | $6.39B | 2.42 |
| 2017-03-31 | $15.28B | $6.08B | 2.51 |
| 2016-12-31 | $14.29B | $5.91B | 2.42 |
| 2016-09-30 | $13.91B | $5.72B | 2.43 |
| 2016-06-30 | $13.96B | $5.54B | 2.52 |
| 2016-03-31 | $13.34B | $5.31B | 2.51 |
| 2015-12-31 | $5.17B | $2.17B | 2.39 |
| 2015-09-30 | $5.27B | $2.05B | 2.57 |
| 2015-06-30 | $5.08B | $1.94B | 2.62 |
| 2015-03-31 | $4.86B | $1.84B | 2.65 |
| 2014-12-31 | $4.08B | $1.74B | 2.34 |
| 2014-09-30 | $3.81B | $1.64B | 2.32 |
| 2014-06-30 | $3.20B | $1.49B | 2.15 |
| 2014-03-31 | $3.02B | $1.42B | 2.13 |
| 2013-12-31 | $2.29B | $1.24B | 1.84 |
| 2013-09-30 | $1.95B | $1.19B | 1.65 |
| 2013-06-30 | $1.92B | $1.12B | 1.71 |
| 2013-03-31 | $1.90B | $0.99B | 1.93 |
| 2012-12-31 | $1.82B | $0.95B | 1.91 |
| 2012-09-30 | $1.73B | $0.96B | 1.81 |
| 2012-06-30 | $1.50B | $0.95B | 1.58 |
| 2012-03-31 | $1.30B | $0.98B | 1.33 |
| 2011-12-31 | $1.25B | $0.94B | 1.34 |
| 2011-09-30 | $1.13B | $0.90B | 1.25 |
| 2011-06-30 | $1.14B | $0.87B | 1.31 |
| 2011-03-31 | $1.17B | $0.83B | 1.41 |
| 2010-12-31 | $1.15B | $0.80B | 1.44 |
| 2010-09-30 | $0.99B | $0.80B | 1.23 |
| 2010-06-30 | $0.95B | $0.78B | 1.23 |
| 2010-03-31 | $0.98B | $0.75B | 1.31 |
| 2009-12-31 | $1.08B | $0.62B | 1.75 |
| 2009-09-30 | $1.04B | $0.59B | 1.76 |
| 2009-06-30 | $1.00B | $0.59B | 1.71 |
| 2009-03-31 | $1.00B | $0.55B | 1.83 |
| 2008-12-31 | $0.95B | $0.50B | 1.90 |
| 2008-09-30 | $0.88B | $0.48B | 1.84 |
| 2008-06-30 | $0.76B | $0.46B | 1.64 |
| 2008-03-31 | $0.70B | $0.44B | 1.57 |
| 2007-12-31 | $0.71B | $0.42B | 1.70 |
| 2007-09-30 | $0.68B | $0.41B | 1.66 |
| 2007-06-30 | $0.66B | $0.39B | 1.69 |
| 2007-03-31 | $0.60B | $0.37B | 1.63 |
| 2006-12-31 | $0.57B | $0.33B | 1.74 |
| 2006-09-30 | $0.51B | $0.31B | 1.66 |
| 2006-06-30 | $0.43B | $0.37B | 1.14 |
| 2006-03-31 | $0.37B | $0.36B | 1.03 |
| 2005-12-31 | $0.32B | $0.35B | 0.90 |
| 2005-09-30 | $0.31B | $0.33B | 0.92 |
| 2005-06-30 | $0.26B | $0.32B | 0.80 |
| 2005-03-31 | $0.27B | $0.29B | 0.93 |
| 2004-12-31 | $0.26B | $0.27B | 0.95 |
| 2004-09-30 | $0.17B | $0.26B | 0.65 |
| 2004-06-30 | $0.15B | $0.24B | 0.61 |
| 2004-03-31 | $0.15B | $0.23B | 0.62 |
| 2003-12-31 | $0.14B | $0.22B | 0.65 |
| 2003-09-30 | $0.12B | $0.21B | 0.58 |
| 2003-06-30 | $0.10B | $0.12B | 0.87 |
| 2003-03-31 | $0.12B | $0.11B | 1.05 |
| 2002-12-31 | $0.11B | $0.10B | 1.06 |
| 2002-09-30 | $0.08B | $0.10B | 0.80 |
| 2002-06-30 | $0.07B | $0.08B | 0.87 |
| 2002-03-31 | $0.08B | $0.07B | 1.10 |
| 2001-12-31 | $0.07B | $0.06B | 1.05 |
| 2001-09-30 | $0.00B | 0.00 | |
| 2001-06-30 | $0.00B | 0.00 | |
| 2001-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Health Maintenance Organizations | $18.343B | $194.777B |
| Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Through a diversified product portfolio and expanding geographic reach, Centene continues to deliver results by growing premium and service revenues profitably. The company operates in two segments: Managed Care and Specialty Services. Managed Care - This segment provides health plan coverage to individuals through Government subsidized programs, including Medicaid. Specialty Services - This segment consists of its specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UnitedHealth Group (UNH) | United States | $276.233B | 18.66 |
| Cigna Group (CI) | United States | $71.482B | 9.09 |
| Humana (HUM) | United States | $23.068B | 11.22 |
| Molina Healthcare (MOH) | United States | $7.599B | 13.70 |
| Select Medical Holdings (SEM) | United States | $2.030B | 14.23 |
| Joint (JYNT) | United States | $0.125B | 0.00 |
| Aethlon Medical (AEMD) | United States | $0.003B | 0.00 |